A Thorough QT/QTc Study to Assess the Effects of Androxal in Healthy Male Subjects
NCT02117830
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
54
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Androxal 25 mg capsules
DRUG:
Androxal 250 Capsules
DRUG:
Placebo Capsules
DRUG:
Moxifloxacin 400 mg
Sponsor
Repros Therapeutics Inc.